Bank of Montreal
VKTX icon

Bank of Montreal’s Viking Therapeutics VKTX Stock Holding History

Bank of Montreal’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,000
Closed -$401K – 4752
2019
Q4 		$401K Hold
50,000
– – ﹤0.01% 2788
2019
Q3 		$344K Hold
50,000
– – ﹤0.01% 2630
2019
Q2 		$415K Buy
50,000
+18,100
+57% +$155K ﹤0.01% 2527
2019
Q1 		$317K Buy
31,900
+5,000
+19% +$41.9K ﹤0.01% 2508
2018
Q4 		$206K Buy
+26,900
New +$322K ﹤0.01% 2560

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bank of Montreal's VKTX Position: Q2 2026 in Review

Bank of Montreal opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 6,305 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #2885 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in VKTX as recently as Q3 2024.

Bank of Montreal first reported a position in VKTX in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.24M in Q4 2019. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Bank of Montreal held 6,305 shares of Viking Therapeutics worth $246K as of Q2 2026.
  • Viking Therapeutics was a new Bank of Montreal position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2885 holding.
  • Bank of Montreal first reported a position in Viking Therapeutics in Q2 2018 and has held it in 19 quarters since.
  • Bank of Montreal's Viking Therapeutics position peaked at $3.24M in Q4 2019.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.